Lucira Health Inc. (NASDAQ:LHDX) went down by -4.46% from its latest closing price compared to the recent 1-year high of $37.99. The company’s stock price has collected -6.85% of loss in the last five trading sessions. Press Release reported on 02/11/21 that U.S. Physicians Can Now Order Lucira Health Self-Administered, Lab Quality, COVID-19 Molecular Test for Home or Office
Is It Worth Investing in Lucira Health Inc. (NASDAQ :LHDX) Right Now?
Opinions of the stock are interesting as 2 analysts out of 3 who provided ratings for Lucira Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $25.50. LHDX currently public float of 36.12M and currently shorts hold a 0.97% ratio of that float. Today, the average trading volume of LHDX was 552.34K shares.
LHDX’s Market Performance
The volatility ratio for the week stands at 7.49% while the volatility levels for the past 30 days are set at 15.08% for Lucira Health Inc.. The simple moving average for the period of the last 20 days is -18.56% for LHDX stocks with a simple moving average of -35.54% for the last 200 days.
Analysts’ Opinion of LHDX
BofA Securities, on the other hand, stated in their research note that they expect to see LHDX reach a price target of $22. The rating they have provided for LHDX stocks is “Neutral” according to the report published on March 02nd, 2021.
LHDX Trading at -35.54% from the 50-Day Moving Average
After a stumble in the market that brought LHDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.75% of loss for the given period.
Volatility was left at 15.08%, however, over the last 30 days, the volatility rate increased by 7.49%, as shares sank -53.33% for the moving average over the last 20 days.
During the last 5 trading sessions, LHDX fell by -6.85%, in comparison to the 20-day moving average, which settled at $16.57. In addition, Lucira Health Inc. saw -43.35% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at LHDX starting from EPIQ Capital Group, LLC, who purchase 3,461,764 shares at the price of $17.00 back on Feb 05. After this action, EPIQ Capital Group, LLC now owns 3,461,764 shares of Lucira Health Inc., valued at $58,849,988 using the latest closing price.
Stock Fundamentals for LHDX
The total capital return value is set at -341.46, while invested capital returns managed to touch -418.74.
Based on Lucira Health Inc. (LHDX), the company’s capital structure generated 20.96 points at debt to equity in total, while total debt to capital is 17.33.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.83.